# Andrew C Sedillo, MD – FDA Inspection, Jun 2, 2016

Source: https://www.keypedia.com/records/fda_inspections/andrew-c-sedillo-md/2fcc55c2-f69b-4201-a936-166cabcc80d7
Source feed: FDA_Inspections

> FDA inspection 982272 of Andrew C Sedillo, MD, June 02, 2016. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 982272
- Company Name: Andrew C Sedillo, MD
- Inspection Date: 2016-06-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1334832 - 2026-09-03](https://www.keypedia.com/records/fda_inspections/andrew-c-sedillo-md/55683424-1fab-433c-bffe-18964e40e053)
- [FDA Inspection 1269750 - 2025-05-07](https://www.keypedia.com/records/fda_inspections/andrew-c-sedillo-md/9c5ac5af-ccfe-4f85-b0a6-652fdea6ab97)
- FDA Inspection 1108035 - 2019-10-11
- FDA Inspection 1044979 - 2018-02-16

Company: https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
